ArticleEBioMedicine2023
BRCA-deficient metastatic prostate cancer has an adverse prognosis and distinct genomic phenotype.
Heidi Fettke et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
28 papers cite it
this papercites it
ArticleEBioMedicine2023
Heidi Fettke et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.